Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Maiko Maruyama-Inoue

Showing results (1-10 of 59) with videos related to

Pageof 6
Sort By:
Ophthalmology|May 2, 2017
Flanged Intrascleral Intraocular Lens Fixation with Double-Needle TechniqueShin Yamane, Shimpei Sato, Maiko Maruyama-Inoue, et al.
Clinical Ophthalmology (Auckland, N.Z.)|October 22, 2019
Predictive Factors And Long-Term Visual Outcomes After Anti-Vascular Endothelial Growth Factor Treatment Of Retinal Angiomatous ProliferationMaiko Maruyama-Inoue, Shimpei Sato, Shin Yamane, et al.
Retina (Philadelphia, Pa.)|August 18, 2017
INTRAVITREAL INJECTION OF AFLIBERCEPT IN PATIENTS WITH POLYPOIDAL CHOROIDAL VASCULOPATHY: A 3-YEAR FOLLOW-UPMaiko Maruyama-Inoue, Shimpei Sato, Shin Yamane, et al.
Plos One|April 18, 2024
Visual outcomes of intraocular inflammation after brolucizumab injection in Japanese patients with neovascular age-related macular degenerationKazushi Hirono, Maiko Maruyama-Inoue, Yasuo Yanagi, et al.
Graefe'S Archive for Clinical and Experimental Ophthalmology = Albrecht Von Graefes Archiv Fur Klinische Und Experimentelle Ophthalmologie|September 26, 2023
Comparison of functional and morphologic changes between brolucizumab and faricimab in neovascular age-related macular degenerationMaiko Maruyama-Inoue, Yasuo Yanagi, Tatsuya Inoue, et al.
Graefe'S Archive for Clinical and Experimental Ophthalmology = Albrecht Von Graefes Archiv Fur Klinische Und Experimentelle Ophthalmologie|September 3, 2018
Variable response of subretinal hyperreflective material to anti-vascular endothelial growth factor classified with optical coherence tomography angiographyMaiko Maruyama-Inoue, Shimpei Sato, Shin Yamane, et al.
Scientific Reports|November 25, 2024
Importance of fluorescein angiography as a predictor of treatment response in patients with pachychoroid neovasculopathyMaiko Maruyama-Inoue, Yasuo Yanagi, Tatsuya Inoue, et al.
Scientific Reports|April 7, 2023
Intravitreal anti-vascular endothelial growth factor monotherapy in age-related macular degeneration with submacular hemorrhageMaiko Maruyama-Inoue, Yoko Kitajima, Yasuo Yanagi, et al.
BMC Ophthalmology|April 14, 2025
Three-year visual outcomes after brolucizumab in patients with neovascular age-related macular degenerationYume Kobayashi, Maiko Maruyama-Inoue, Tatsuya Inoue, et al.
Journal of Vitreoretinal Diseases|March 3, 2026
Comparison of Short-term Outcomes Between Faricimab and High-Dose Aflibercept in Patients With Neovascular Age-related Macular DegenerationMizuho Shiratori, Maiko Maruyama-Inoue, Yasuo Yanagi, et al.
Pageof 6

Showing results (1-10 of 59) with videos related to

Sort By:
Pageof 6
Ophthalmology|May 2, 2017
Flanged Intrascleral Intraocular Lens Fixation with Double-Needle TechniqueShin Yamane, Shimpei Sato, Maiko Maruyama-Inoue, et al.
Clinical Ophthalmology (Auckland, N.Z.)|October 22, 2019
Predictive Factors And Long-Term Visual Outcomes After Anti-Vascular Endothelial Growth Factor Treatment Of Retinal Angiomatous ProliferationMaiko Maruyama-Inoue, Shimpei Sato, Shin Yamane, et al.
Retina (Philadelphia, Pa.)|August 18, 2017
INTRAVITREAL INJECTION OF AFLIBERCEPT IN PATIENTS WITH POLYPOIDAL CHOROIDAL VASCULOPATHY: A 3-YEAR FOLLOW-UPMaiko Maruyama-Inoue, Shimpei Sato, Shin Yamane, et al.
Plos One|April 18, 2024
Visual outcomes of intraocular inflammation after brolucizumab injection in Japanese patients with neovascular age-related macular degenerationKazushi Hirono, Maiko Maruyama-Inoue, Yasuo Yanagi, et al.
Graefe'S Archive for Clinical and Experimental Ophthalmology = Albrecht Von Graefes Archiv Fur Klinische Und Experimentelle Ophthalmologie|September 26, 2023
Comparison of functional and morphologic changes between brolucizumab and faricimab in neovascular age-related macular degenerationMaiko Maruyama-Inoue, Yasuo Yanagi, Tatsuya Inoue, et al.
Graefe'S Archive for Clinical and Experimental Ophthalmology = Albrecht Von Graefes Archiv Fur Klinische Und Experimentelle Ophthalmologie|September 3, 2018
Variable response of subretinal hyperreflective material to anti-vascular endothelial growth factor classified with optical coherence tomography angiographyMaiko Maruyama-Inoue, Shimpei Sato, Shin Yamane, et al.
Scientific Reports|November 25, 2024
Importance of fluorescein angiography as a predictor of treatment response in patients with pachychoroid neovasculopathyMaiko Maruyama-Inoue, Yasuo Yanagi, Tatsuya Inoue, et al.
Scientific Reports|April 7, 2023
Intravitreal anti-vascular endothelial growth factor monotherapy in age-related macular degeneration with submacular hemorrhageMaiko Maruyama-Inoue, Yoko Kitajima, Yasuo Yanagi, et al.
BMC Ophthalmology|April 14, 2025
Three-year visual outcomes after brolucizumab in patients with neovascular age-related macular degenerationYume Kobayashi, Maiko Maruyama-Inoue, Tatsuya Inoue, et al.
Journal of Vitreoretinal Diseases|March 3, 2026
Comparison of Short-term Outcomes Between Faricimab and High-Dose Aflibercept in Patients With Neovascular Age-related Macular DegenerationMizuho Shiratori, Maiko Maruyama-Inoue, Yasuo Yanagi, et al.
Pageof 6